He has focused in his research on clarifying the
electrophysiologic mechanisms of the
nucleosideadenosine, current-based
defibrillation, and determining the role of mechanoelectrical feedback as a stimulus for causing malignant
ventricular arrhythmias.[2] He has been issued 4
patents.[2] Lerman has focused in his clinical work on the diagnosis and treatment by
ablation of complicated atrial and ventricular
arrhythmias, and treating life-threatening arrhythmias with implantable devices.[2]
"Sex-based differences in outcomes, 30-day readmissions, and costs following catheter ablation of atrial fibrillation: the United States Nationwide Readmissions Database 2010-14." European Heart Journal. 2019
"The anatomic substrates for outflow tract arrhythmias." Heart Rhythm. 2019
"Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban." Heart Rhythm. 2018
"Fluoroless catheter ablation of atrial fibrillation." Heart Rhythm. 2017
"Limitations of dormant conduction as a predictor of atrial fibrillation recurrence and pulmonary vein reconnection after catheter ablation." PACE - Pacing and Clinical Electrophysiology. 2015
"Differentiation of Papillary Muscle from Fascicular and Mitral Annular Ventricular Arrhythmias in Patients with and Without Structural Heart Disease." Circulation: Arrhythmia and Electrophysiology. 2015
"Ubiquitous myocardial extensions into the pulmonary artery demonstrated by integrated intracardiac echocardiography and electroanatomic mapping: changing the paradigm of idiopathic right ventricular outflow tract arrhythmias." Circulation: Arrhythmia and Electrophysiology. 2014
Dr. Craig T. Basson, MD, PhD, Dr. Bruce B. Lerman, MD (2009), Topics in Arrhythmias and Ischemic Heart Disease, Demos Medical Publishing.[10]